Biotricity Inc (OTCPK:BTCY)

Q1 2026 Biotricity Inc Earnings Call Transcript

Aug 14, 2025 / 08:30 PM GMT

Release Date Price: $0.54

Transcript 10-Q

Key Points

Positve

Biotricity Inc (BTCY) achieved a significant milestone by reporting positive EBITDA for the first time in its history, indicating a path towards profitability.
The company reported a 21% increase in revenue for the first quarter of fiscal 2026, reaching $3.9 million, driven by strong market adoption of its technology.
Biotricity Inc (BTCY) has expanded its cardiac AI cloud platform through strategic partnerships with Amazon AWS and Google's Tensorflow, enhancing diagnostic accuracy and patient outcomes.
The company has secured regulatory approvals in multiple international markets, including Canada, Saudi Arabia, and Argentina, aligning with its strategy for global expansion.
Gross profit for the quarter increased by 31.9% to $3.1 million, with a gross profit margin improvement to 80.5%, reflecting operational efficiencies and a strong recurring revenue base.

Negative

Despite improvements, Biotricity Inc (BTCY) reported a net loss of $754,000 for the first quarter, although this was a significant improvement from the prior year's loss.
The company faces challenges with rising variable interest rates, which could impact future financial performance.
Biotricity Inc (BTCY) is still in the process of pursuing FDA clearance for its AI clinical model, which could delay the full commercialization of its new technologies.
Operating expenses, although reduced, remain a concern as the company continues to invest in R&D and sales force transformation.
The company's expansion into new verticals and international markets may require significant resources and could face regulatory and competitive challenges.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

BTCY.PK - Biotricity Inc
Q1 2026 Biotricity Inc Earnings Call
Aug 14, 2025 / 08:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good afternoon and welcome to Biotricity's first quarter fiscal 2026 financial results and business update conference call. Today's conference is being recorded. As a reminder, this is Biotricity's first quarter, fiscal 2026, ended on June 30, 2025. So all figures presented for this period will reflect that end date. Earlier, Bioricity issued its earnings press release for the period which highlighted financial and operational results. A copy of the press release is available on the investor relations section of the Biotricity website, and the full financials have been filed with the SEC on Form 10Q and posted on Edgar at www.SEC.gov.

Before beginning the company's formal remarks, I'd like to remind listeners that today's discussion may

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.